The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
Source link
This is from today’s news)
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
Source link
This is from today’s news)